4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-046486
President & CEO sold 13,759 shares at $4.76 ($65,493)
- President & CEO acquired 410,625 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2022-08-15 | Grant or award | +410,625 | 1,031,566 | D | ||
| ROBIN HOWARD W President & CEO | 2022-08-16 | Sale | −13,759 | $4.76 | $65,493 | 1,017,807 | D |
| Derivatives | |||||||
| ROBIN HOWARD W President & CEO | 2022-08-15 | Grant or award · Common Stock | +821,250 | 821,250 | D | ||
| Open-market sales · 13,759 sh · avg $4.76 · $65,493 | |||||||
Loading xslF345X03/doc4.xml…